1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in the Netherlands

Biotechnology in the Netherlands

  • February 2015
  • -
  • MarketLine
  • -
  • 33 pages

Introduction

Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

*The Dutch biotechnology industry had total revenues of $352.1m in 2014, representing a compound annual growth rate (CAGR) of 0.8% between 2010 and 2014.

*The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $265m, equivalent to 75.3% of the industry's overall value.

*The performance of the industry is forecast to accelerate, with an anticipated CAGR of 4.7% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $441.9m by the end of 2019.

Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in the Netherlands

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the Netherlands

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Netherlands economy

Key Questions Answered

What was the size of the Netherlands biotechnology market by value in 2014?

What will be the size of the Netherlands biotechnology market in 2019?

What factors are affecting the strength of competition in the Netherlands biotechnology market?

How has the market performed over the last five years?

Table Of Contents

Biotechnology in the Netherlands
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 16
Degree of rivalry 17
Leading Companies 18
Actelion Ltd 18
AstraZeneca PLC 21
Biogen Idec, Inc. 24
Crucell N.V. 27
Macroeconomic Indicators 28
Country Data 28
Methodology 30
Industry associations 31
Related MarketLine research 31
Appendix 32
About MarketLine 32

LIST OF TABLES
Table 1: Netherlands biotechnology industry value: $ million, 2010-14(e) 8
Table 2: Netherlands biotechnology industry category segmentation: $ million, 2014(e) 9
Table 3: Netherlands biotechnology industry geography segmentation: $ million, 2014(e) 10
Table 4: Netherlands biotechnology industry value forecast: $ million, 2014-19 11
Table 5: Actelion Ltd: key facts 18
Table 6: Actelion Ltd: key financials ($) 19
Table 7: Actelion Ltd: key financials (CHF) 19
Table 8: Actelion Ltd: key financial ratios 19
Table 9: AstraZeneca PLC: key facts 21
Table 10: AstraZeneca PLC: key financials ($) 22
Table 11: AstraZeneca PLC: key financial ratios 22
Table 12: Biogen Idec, Inc.: key facts 24
Table 13: Biogen Idec, Inc.: key financials ($) 25
Table 14: Biogen Idec, Inc.: key financial ratios 25
Table 15: Crucell N.V.: key facts 27
Table 16: Netherlands size of population (million), 2010-14 28
Table 17: Netherlands gdp (constant 2005 prices, $ billion), 2010-14 28
Table 18: Netherlands gdp (current prices, $ billion), 2010-14 28
Table 19: Netherlands inflation, 2010-14 29
Table 20: Netherlands consumer price index (absolute), 2010-14 29
Table 21: Netherlands exchange rate, 2010-14 29

LIST OF FIGURES
Figure 1: Netherlands biotechnology industry value: $ million, 2010-14(e) 8
Figure 2: Netherlands biotechnology industry category segmentation: % share, by value, 2014(e) 9
Figure 3: Netherlands biotechnology industry geography segmentation: % share, by value, 2014(e) 10
Figure 4: Netherlands biotechnology industry value forecast: $ million, 2014-19 11
Figure 5: Forces driving competition in the biotechnology industry in the Netherlands, 2014 12
Figure 6: Drivers of buyer power in the biotechnology industry in the Netherlands, 2014 13
Figure 7: Drivers of supplier power in the biotechnology industry in the Netherlands, 2014 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the Netherlands, 2014 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the Netherlands, 2014 16
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the Netherlands, 2014 17
Figure 11: Actelion Ltd: revenues and profitability 20
Figure 12: Actelion Ltd: assets and liabilities 20
Figure 13: AstraZeneca PLC: revenues and profitability 23
Figure 14: AstraZeneca PLC: assets and liabilities 23
Figure 15: Biogen Idec, Inc.: revenues and profitability 26
Figure 16: Biogen Idec, Inc.: assets and liabilities 26


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...

Sample Preparation Market by Product , Consumables ), Application , End Users  - Global Forecast to 2021

Sample Preparation Market by Product , Consumables ), Application , End Users - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves ...

Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

Trends In Gene Therapy

July 2016 $ 5 000

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.